Key stats
About Themes US R&D Champions ETF
Expense ratio
0.29%
Home page
Inception date
Dec 13, 2023
USRD strives to track the performance of the Solactive US R&D Champions Index, targeting US firms that prioritize and consistently invest in Research & Development (R&D) while maintaining profitability. The fund employs a passive investment strategy, capturing the top 50 highest-ranked large- and mid-cap companies as per R&D spending ratio. Criteria for selection include exhibiting an increase in R&D investment that is reported in public filings, positive profit margins over the last three years, and solid returns on equity and assets for three consecutive years. Each company is then ranked and equally weighted, ensuring the funds investment is distributed uniformly across these innovation leaders. USRD aims to provide diversified exposure to leading R&D-centric US companies. The fund is rebalanced seven business days after the quarterly Selection Days in January, April, July, and October.
Classification
What's in the fund
Exposure type
Technology Services
Electronic Technology
Health Technology
Stock breakdown by region